Crestor (Rosuvastatin) is a popular prescription medication used to reduce the amount of cholesterol in your blood. Crestor, which is manufactured by AstraZeneca, was approved for use by the U.S. Food and Drug Administration (“FDA”), in August of 2003. Since that time, there have been several warnings issued by the FDA relating cholesterol lowering drugs (i.e. – statins) and serious adverse events.
A 2009 study, published in The Lancet, suggested that statins such as Crestor cause serious heart muscle problems, including cardiomyopathy. Cardiomyopathy, which means “heart muscle disease,” is a deterioration of the heart muscle. Patients may experience difficulty breathing, swelling of the feet or ankles, rapid heartbeat and other symptoms. The Lancet article explained that the study’s results “might be a reduction in the concentration of coenzyme Q10 or ubiquinone, which is known to be caused by statins.”
Our firm is currently investigating claims involving Crestor use and cardiomyopathy.
Lawyer: Chad Cook
Primary Contact: Tabitha Dean
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.